Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Single Dose-Escalation Safety Study of Human Glucocerebrosidase (prGCD)
This study has been completed.
Study NCT00258778   Information provided by Protalix
First Received: November 23, 2005   Last Updated: December 4, 2006   History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been completed.
  Estimated Study Completion Date: January 2006
  Estimated Primary Completion Date: No date given
No publications provided by Protalix

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Aviezer D, Brill-Almon E, Shaaltiel Y, Hashmueli S, Bartfeld D, Mizrachi S, Liberman Y, Freeman A, Zimran A, Galun E. A plant-derived recombinant human glucocerebrosidase enzyme--a preclinical and phase I investigation. PLoS ONE. 2009;4(3):e4792. Epub 2009 Mar 11.




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services